Related Experiment Video

Updated: Jun 24, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure

Deddo Moertl1, Rudolf Berger, Alexandra Hammer

  • 1Department of Cardiology, Medical University of Vienna, Vienna, Austria. deddo.moertl@meduniwien.ac.at

Journal of Cardiac Failure
|March 31, 2009
PubMed

Insights

Home-based nurse care (HBNC) benefits chronic heart failure patients with high B-type natriuretic peptide (BNP) levels. High BNP predicts improved outcomes, aiding patient selection for this intervention.

Area of Science:

  • Cardiology
  • Nursing Care

Background:

  • Home-based nurse care (HBNC) is known to reduce adverse events in chronic heart failure (CHF) patients.
  • Identifying which CHF patients benefit most from HBNC is crucial for optimizing care.
  • B-type natriuretic peptide (BNP) is a significant prognostic marker in CHF.

Purpose of the Study:

  • To investigate whether B-type natriuretic peptide (BNP) levels can predict the benefit of home-based nurse care (HBNC) in patients with chronic heart failure.
  • To determine if BNP can serve as a selection criterion for HBNC interventions.

Main Methods:

  • A randomized controlled trial involving 96 patients post-heart failure hospitalization.
  • Patients were assigned to either 12 months of HBNC or usual care.
  • B-type natriuretic peptide (BNP) levels were measured, with the median value used as a cutoff to predict benefit.

Main Results:

  • HBNC significantly reduced the combined endpoint of death or heart failure hospitalization at both 12 and 24 months.
  • Patients with supramedian BNP levels showed a significant reduction in the endpoint with HBNC at 12 and 24 months.
  • Patients with inframedian BNP levels did not experience significant changes in the endpoint with HBNC.

Conclusions:

  • Elevated B-type natriuretic peptide (BNP) levels can predict a positive response to home-based nurse care (HBNC) in chronic heart failure patients.
  • BNP measurement may assist in selecting appropriate candidates for HBNC interventions, thereby improving resource allocation and patient outcomes.
Abstract

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...